Analysts expect that MaxLinear, Inc. (NYSE:MXL) will post $87.06 million in sales for the current fiscal quarter, Zacks reports. Four analysts have issued estimates for MaxLinear’s earnings. The lowest sales estimate is $87.00 million and the highest is $87.24 million. MaxLinear posted sales of $113.72 million in the same quarter last year, which suggests a negative year over year growth rate of 23.4%. The firm is scheduled to report its next quarterly earnings report on Tuesday, February 12th.
On average, analysts expect that MaxLinear will report full year sales of $384.45 million for the current financial year, with estimates ranging from $384.40 million to $384.61 million. For the next fiscal year, analysts anticipate that the business will post sales of $392.28 million, with estimates ranging from $392.00 million to $392.50 million. Zacks’ sales calculations are a mean average based on a survey of research firms that that provide coverage for MaxLinear.
MaxLinear (NYSE:MXL) last announced its quarterly earnings results on Tuesday, October 30th. The semiconductor company reported $0.19 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.18 by $0.01. The company had revenue of $85.00 million during the quarter, compared to analysts’ expectations of $85.01 million. MaxLinear had a positive return on equity of 15.35% and a negative net margin of 11.18%. The firm’s quarterly revenue was down 25.2% compared to the same quarter last year. During the same period in the previous year, the business earned $0.39 earnings per share.
MXL has been the subject of several recent research reports. Needham & Company LLC reiterated a “buy” rating and issued a $20.00 price target on shares of MaxLinear in a research report on Wednesday, October 31st. Susquehanna Bancshares cut MaxLinear from a “positive” rating to a “neutral” rating and reduced their price target for the company from $21.00 to $18.00 in a research report on Thursday, October 25th. UBS Group cut MaxLinear from a “positive” rating to a “neutral” rating in a research report on Thursday, October 25th. Finally, Zacks Investment Research upgraded MaxLinear from a “sell” rating to a “hold” rating in a research report on Saturday, August 18th. Two investment analysts have rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the company. MaxLinear presently has an average rating of “Hold” and an average price target of $22.60.
In related news, VP William Torgerson sold 12,500 shares of the business’s stock in a transaction dated Thursday, December 6th. The stock was sold at an average price of $19.61, for a total transaction of $245,125.00. Following the completion of the transaction, the vice president now directly owns 104,761 shares in the company, valued at $2,054,363.21. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, VP Michael J. Lachance sold 50,000 shares of the business’s stock in a transaction dated Tuesday, December 4th. The stock was sold at an average price of $20.75, for a total value of $1,037,500.00. Following the transaction, the vice president now owns 131,232 shares of the company’s stock, valued at $2,723,064. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 63,000 shares of company stock valued at $1,292,410. 11.47% of the stock is owned by company insiders.
A number of institutional investors have recently bought and sold shares of the stock. OppenheimerFunds Inc. grew its position in MaxLinear by 29.0% during the second quarter. OppenheimerFunds Inc. now owns 13,990 shares of the semiconductor company’s stock worth $218,000 after buying an additional 3,146 shares in the last quarter. Virginia Retirement Systems ET AL grew its position in MaxLinear by 18.6% during the second quarter. Virginia Retirement Systems ET AL now owns 28,100 shares of the semiconductor company’s stock worth $438,000 after buying an additional 4,400 shares in the last quarter. Riverhead Capital Management LLC grew its position in MaxLinear by 68.8% during the third quarter. Riverhead Capital Management LLC now owns 10,800 shares of the semiconductor company’s stock worth $215,000 after buying an additional 4,400 shares in the last quarter. Rhumbline Advisers grew its position in MaxLinear by 3.4% during the second quarter. Rhumbline Advisers now owns 147,605 shares of the semiconductor company’s stock worth $2,301,000 after buying an additional 4,797 shares in the last quarter. Finally, Mutual of America Capital Management LLC grew its position in MaxLinear by 1.8% during the third quarter. Mutual of America Capital Management LLC now owns 286,773 shares of the semiconductor company’s stock worth $5,701,000 after buying an additional 5,045 shares in the last quarter.
Shares of NYSE MXL traded down $0.84 during mid-day trading on Tuesday, hitting $18.88. The company had a trading volume of 526,997 shares, compared to its average volume of 481,492. The stock has a market cap of $1.30 billion, a PE ratio of 16.00, a price-to-earnings-growth ratio of 1.40 and a beta of 0.90. MaxLinear has a 1 year low of $14.87 and a 1 year high of $28.06. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.99 and a current ratio of 2.62.
MaxLinear Company Profile
MaxLinear, Inc provides radio-frequency (RF), high-performance analog, and mixed-signal communications systems-on-chip solutions (SoCs) for the connected home, wired and wireless infrastructure, and industrial and multi-market applications worldwide. The company offers range of semiconductor products, such as RF receivers and RF receiver SoCs, wireless infrastructure backhaul RF receivers and modem SoCs, laser modulator drivers, transimpedance amplifiers, clock and data recovery circuits, interface solutions, power management products, and data encryption and compression products.
See Also: Debt-To-Equity Ratio
Get a free copy of the Zacks research report on MaxLinear (MXL)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for MaxLinear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MaxLinear and related companies with MarketBeat.com's FREE daily email newsletter.